Editing Medication (section)

===United States===
{{main|Prescription drug prices in the United States}}
In the United States, drug costs are partially unregulated, but instead are the result of negotiations between drug companies and insurance companies.<ref>{{Cite book|title=Social welfare policy for a sustainable future : the U.S. in global context|first1=Katherine S.|last1=van Wormer |last2=Link |first2=Rosemary J.|isbn=978-1-4522-4031-2|location=Los Angeles|oclc=899880624|date = 18 March 2015 |publisher=SAGE}}</ref>

High prices have been attributed to monopolies given to manufacturers by the government.<ref>{{cite journal|last1=Kesselheim|first1=Aaron S.|last2=Avorn|first2=Jerry|last3=Sarpatwari|first3=Ameet|title=The High Cost of Prescription Drugs in the United States|journal=JAMA|date=23 August 2016|volume=316|issue=8|pages=858–71|doi=10.1001/jama.2016.11237|pmid=27552619|s2cid=19317308}}</ref> New drug development costs continue to rise as well. Despite the enormous advances in science and technology, the number of new blockbuster drugs approved by the government per billion dollars spent has halved every 9 years since 1950.<ref>{{Cite journal|last1=Scannell|first1=Jack W.|last2=Blanckley|first2=Alex|last3=Boldon|first3=Helen|last4=Warrington |first4=Brian|date=1 March 2012 |title=Diagnosing the decline in pharmaceutical R&D efficiency|journal=Nature Reviews Drug Discovery|language=En|volume=11 |issue=3|pages=191–200|doi=10.1038/nrd3681|pmid=22378269|s2cid=3344476|issn=1474-1776}}</ref>